Clinical Trial Update: Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating perioperative eltrombopag in patients with inherited thrombocytopenia has completed. Sponsor: University Hospital, Toulouse.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Thrombocytopenia | Phase 2 | Status: COMPLETED